Keynote Speakers

Sunday, October 20

Victoria Sweet, MD, PhD
Slow Medicine, Fast Medicine: Putting Them Both Together
Dr. Victoria Sweet

Dr. Sweet is an Associate Clinical Professor of Medicine at the University of California, San Francisco, and a prize-winning historian with a Ph.D. in medical history. She practiced medicine for twenty years at Laguna Honda Hospital in San Francisco, where she began writing.

In her recent book, God's Hotel: A Doctor, a Hospital, and a Pilgrimage to the Heart of Medicine (Riverhead, 2012), she lays out her evidence—in stories of her patients and her hospital—for some new ideas about medicine and healthcare in this country. In trying to get control of healthcare costs by emphasizing "efficiency,"we've headed down a wrong path. Medicine works best—that is, arrives at the right diagnosis and the right treatment for the least cost—when the doctor has enough time to do a good job, and pays attention not only to the patient but to what's around the patient. Dr. Sweet calls this approach Slow Medicine, and she believes that, put into wider practice, it would be not only more satisfying for patient and doctor, but also less expensive. Her Ecomedicine Project and Second Opinion Clinic are conceived to show this. The New York Times calls her ideas "hard-core subversion"; Vanity Fair judges the book to be a "radical and compassionate alternative to modern healthcare," and Health Affairs describes Dr. Sweet as a "visionary."

Dr. Sweet speaks frequently to medical professionals and the public about Slow Medicine and related topics. Her published work also includes a book on the twelfth century mystic and medical practitioner, Hildegard of Bingen: Rooted in the Earth, Rooted in the Sky: Hildegard of Bingen and Premodern Medicine (Routledge, 2006), and the prize winning essay, "Hildegard of Bingen and the Greening of Medieval Medicine,"(BHM, 1999.


Monday, October 21

Kerry S. Courneya, PhD
Physical Activity and Cancer Prevention/Survivorship
Dr. Kerry Courneya

Dr. Courneya is a professor and Canada research chair in Physical Activity and Cancer at the University of Alberta in Edmonton, Canada. He received his BA and MA in Physical Education from the University of Western Ontario and his PhD in Kinesiology from the University of Illinois (Urbana-Champaign). He spent five years as an assistant/associate professor at the University of Calgary before moving to the University of Alberta where he was promoted to full professor in 2000. Professor Courneya’s research program focuses on physical activity and cancer including prevention, coping with treatments, recovery after treatments, and long term survivorship. He is study co-chair for the Colon Health and Life-Long Exercise Change (CHALLENGE) Trial designed to determine the effects of exercise on disease-free survival in 962 colon cancer survivors across Canada and Australia. He is also team co-leader for the Alberta Moving Beyond Breast Cancer (AMBER) Cohort Study designed to determine the associations between physical activity, health-related fitness and disease outcomes in 1,500 newly diagnosed Alberta breast cancer survivors. He has co-authored the American Cancer Society’s physical activity and nutrition guidelines (2006) and the American College of Sports Medicine’s exercise guidelines for cancer survivors (2010).

Tuesday, October 22

Frank Meyskens, MD, FACP
Chemoprevention Through Natural Health Products
Dr. Frank Meyskens
Dr. Meyskens received his MD and Internal Medicine Training from the University of California, San Francisco. He did his Medical Oncology training at the National Institutes of Health. During that time he also conducted molecular biology investigations in the Laboratory of Tumor Cell Biology. He developed his career at the Arizona Cancer Center at the University of Arizona and was its associate director of cancer prevention and control from 1984 to 1989. While there, he established one of the most successful cancer prevention research programs in the world, and became internationally recognized for his work in the biological activities of retinoids and their clinical usage in the prevention and treatment of human cancers. In 1986, Dr. Meyskens was also asked to establish a cancer prevention and control emphasis within the American Society of Clinical Oncology. A permanent Cancer Prevention and Control Committee was formulated in 1987, of which Dr. Meyskens was founding chair from 1987 to 1990. Under his tutelage, cancer prevention and control issues began to be addressed within this heavily therapeutically oriented society, an emphasis which has become integral to the Society for Integrative Oncology in the last few years.